{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:23:50Z","timestamp":1790987030704,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008478","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.lpm.2024.104263","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T19:24:08Z","timestamp":1733772248000},"page":"104263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Imaging in multiple myeloma"],"prefix":"10.1016","volume":"54","author":[{"given":"Jas","family":"Virk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1778-0010","authenticated-orcid":false,"given":"Jens","family":"Hillengass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.lpm.2024.104263_bib0001","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"The Lancet Oncology"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0003","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41467-017-00296-y","article-title":"Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing","volume":"8","author":"Rasche","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0004","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41467-022-28266-z","article-title":"Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma","volume":"13","author":"Merz","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.lpm.2024.104263_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116857","article-title":"Identification of focal lesion characteristics in MRI which indicate presence of corresponding osteolytic lesion in CT in patients with multiple myeloma","volume":"175","author":"Hildenbrand","year":"2023","journal-title":"Bone"},{"key":"10.1016\/j.lpm.2024.104263_bib0006","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejmp.2019.06.012","article-title":"Radiation dosimetry considerations for skeletal survey imaging of multiple myeloma","volume":"64","author":"Boyd","year":"2019","journal-title":"Phys Med"},{"issue":"3","key":"10.1016\/j.lpm.2024.104263_bib0007","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s11899-017-0379-9","article-title":"The Critical Role of Imaging in the Management of Multiple Myeloma","volume":"12","author":"Raza","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"issue":"2","key":"10.1016\/j.lpm.2024.104263_bib0008","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0009-9260(67)80010-2","article-title":"The radiological demonstration of osseous metastases. Experimental observations","volume":"18","author":"Edelstyn","year":"1967","journal-title":"Clinical Radiology"},{"issue":"6","key":"10.1016\/j.lpm.2024.104263_bib0009","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2","article-title":"International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders","volume":"20","author":"Hillengass","year":"2019","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.lpm.2024.104263_bib0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.thj.6200312","article-title":"Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation","volume":"4","author":"Durie","year":"2003","journal-title":"Hematol J"},{"issue":"8","key":"10.1016\/j.lpm.2024.104263_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.78","article-title":"Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group","volume":"7","author":"Hillengass","year":"2017","journal-title":"Blood Cancer J"},{"issue":"17","key":"10.1016\/j.lpm.2024.104263_bib0012","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.3390\/ijms23179895","article-title":"11C-Methionine PET\/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET\/CT and Prognostic Value","volume":"23","author":"Morales-Lozano","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.lpm.2024.104263_bib0013","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12149-014-0931-9","article-title":"Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET\/CT for the detection of active lesions of multiple myeloma","volume":"29","author":"Okasaki","year":"2015","journal-title":"Ann Nucl Med"},{"issue":"3","key":"10.1016\/j.lpm.2024.104263_bib0014","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1148\/radiol.2020192621","article-title":"CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging","volume":"295","author":"Ulaner","year":"2020","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.lpm.2024.104263_bib0015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1182\/blood-2017-09-807263","article-title":"Copper 64-labeled daratumumab as a PET\/CT imaging tracer for multiple myeloma","volume":"131","author":"Caserta","year":"2018","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.lpm.2024.104263_bib0016","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2009-03-213280","article-title":"F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma","volume":"114","author":"Bartel","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.lpm.2024.104263_bib0017","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/blood-2018-08-825356","article-title":"Imaging in multiple myeloma: How? When?","volume":"133","author":"Zamagni","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.lpm.2024.104263_bib0018","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/RLU.0b013e31825b2071","article-title":"FDG PET or PET\/CT for detecting intramedullary and extramedullary lesions in multiple Myeloma: a systematic review and meta-analysis","volume":"37","author":"Lu","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10.1016\/j.lpm.2024.104263_bib0019","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/ajh.25846","article-title":"Role of imaging in multiple myeloma","volume":"95","author":"Baffour","year":"2020","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.lpm.2024.104263_bib0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/leu.2015.291","article-title":"18F-FDG PET\/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease","volume":"30","author":"Zamagni","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0021","article-title":"Multiple Myeloma: A Review of Imaging Features and Radiological Techniques","volume":"2011","author":"Healy","year":"2011","journal-title":"Bone Marrow Res"},{"issue":"8","key":"10.1016\/j.lpm.2024.104263_bib0022","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3390\/life13081701","article-title":"Current and Future PET Imaging for Multiple Myeloma","volume":"13","author":"Ishibashi","year":"2023","journal-title":"Life"},{"issue":"2","key":"10.1016\/j.lpm.2024.104263_bib0023","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/j.sult.2020.08.019","article-title":"Multiple Myeloma: Role of Imaging in Diagnosis, Staging, and Treatment Response Assessment","volume":"42","author":"Nassar","year":"2021","journal-title":"Semin Ultrasound CT MRI"},{"issue":"10","key":"10.1016\/j.lpm.2024.104263_bib0024","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1182\/blood-2012-08-451690","article-title":"Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3","volume":"121","author":"Usmani","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lpm.2024.104263_bib0025","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2214\/AJR.08.1633","article-title":"Whole-Body MRI versus PET in assessment of multiple myeloma disease activity","volume":"192","author":"Shortt","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.lpm.2024.104263_bib0026","doi-asserted-by":"crossref","first-page":"590","DOI":"10.47102\/annals-acadmedsg.2022414","article-title":"Clinical utility of PET\/MRI in multiple myeloma","volume":"52","author":"Soekojo","year":"2023","journal-title":"Ann Acad Med Singap"},{"issue":"4","key":"10.1016\/j.lpm.2024.104263_bib0027","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2214\/ajr.167.4.8819407","article-title":"Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates","volume":"167","author":"St\u00e4bler","year":"1996","journal-title":"Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.lpm.2024.104263_bib0028","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1148\/radiol.2522081756","article-title":"Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging","volume":"252","author":"B\u00e4uerle","year":"2009","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.lpm.2024.104263_bib0029","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1200\/JCO.2006.08.5803","article-title":"Magnetic Resonance Imaging in Multiple Myeloma: Diagnostic and Clinical Implications","volume":"25","author":"Walker","year":"2007","journal-title":"JCO"},{"issue":"4","key":"10.1016\/j.lpm.2024.104263_bib0030","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1148\/rg.2019180096","article-title":"Whole-Body Imaging of Multiple Myeloma: Diagnostic Criteria","volume":"39","author":"Ormond Filho","year":"2019","journal-title":"RadioGraphics"},{"issue":"4","key":"10.1016\/j.lpm.2024.104263_bib0031","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2214\/AJR.07.2635","article-title":"Whole-body MRI versus whole-body MDCT for staging of multiple myeloma","volume":"190","author":"Baur-Melnyk","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.lpm.2024.104263_bib0032","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2014.57.9961","article-title":"Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement","volume":"33","author":"Dimopoulos","year":"2015","journal-title":"JCO"},{"issue":"6","key":"10.1016\/j.lpm.2024.104263_bib0033","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2214\/AJR.06.1403","article-title":"Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology","volume":"188","author":"Koh","year":"2007","journal-title":"Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.lpm.2024.104263_bib0034","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3390\/hemato2040044","article-title":"Diffusion-Weighted MRI\u2013The Way Forward for MRI in Myeloma?","volume":"2","author":"Hillengass","year":"2021","journal-title":"Hemato"},{"issue":"6","key":"10.1016\/j.lpm.2024.104263_bib0035","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.diii.2013.01.005","article-title":"Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma","volume":"94","author":"Narquin","year":"2013","journal-title":"Diagnostic and Interventional Imaging"},{"issue":"6","key":"10.1016\/j.lpm.2024.104263_bib0036","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/0284185114538792","article-title":"Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging","volume":"56","author":"Squillaci","year":"2015","journal-title":"Acta Radiol"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0037","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jmri.20349","article-title":"Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: A comparative study with histology and clinical markers","volume":"22","author":"Nos\u00e0s-Garcia","year":"2005","journal-title":"Magnetic Resonance Imaging"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0038","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1158\/1078-0432.CCR-14-1029","article-title":"Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma","volume":"21","author":"Merz","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0039","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00256-021-03903-8","article-title":"Review of diffusion-weighted imaging and dynamic contrast\u2013enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma)","volume":"51","author":"Van Den Berghe","year":"2022","journal-title":"Skeletal Radiol"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/bjh.14038","article-title":"Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma","volume":"174","author":"Hillengass","year":"2016","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0041","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/jcm13010264","article-title":"Imaging of Multiple Myeloma: Present and Future","volume":"13","author":"Rodr\u00edguez-Laval","year":"2024","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.lpm.2024.104263_bib0042","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.87","article-title":"Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy","volume":"5","author":"Siontis","year":"2015","journal-title":"Blood Cancer Journal"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0043","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/j.seminoncol.2022.01.007","article-title":"Modern radiographic imaging in multiple myeloma, what is the minimum requirement?","volume":"49","author":"Mena","year":"2022","journal-title":"Semin Oncol"},{"issue":"8","key":"10.1016\/j.lpm.2024.104263_bib0044","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/cncr.22572","article-title":"The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma","volume":"109","author":"Horger","year":"2007","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.lpm.2024.104263_bib0045","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1158\/1078-0432.CCR-15-0396","article-title":"PET\/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma","volume":"21","author":"Zamagni","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"26","key":"10.1016\/j.lpm.2024.104263_bib0046","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.lpm.2024.104263_bib0047","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1200\/JCO.2017.72.2975","volume":"35","author":"Moreau","year":"2017","journal-title":"JCO"},{"issue":"7","key":"10.1016\/j.lpm.2024.104263_bib0048","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/s41375-018-0329-0","article-title":"Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma","volume":"33","author":"Rasche","year":"2019","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.lpm.2024.104263_bib0049","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/annonc\/mdi362","article-title":"Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma","volume":"16","author":"Moulopoulos","year":"2005","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.lpm.2024.104263_bib0050","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/leu.2014.75","article-title":"Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma","volume":"28","author":"Merz","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0051","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bjh.18232","article-title":"Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damage","volume":"199","author":"Wennmann","year":"2022","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.lpm.2024.104263_bib0052","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3324\/haematol.2012.065359","article-title":"Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma","volume":"97","author":"Hillengass","year":"2012","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.lpm.2024.104263_bib0053","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2009.25.5356","article-title":"Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma","volume":"28","author":"Hillengass","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2024.104263_bib0054","doi-asserted-by":"crossref","unstructured":"Pfleger R, Sharma R, Worsley C. Deauville five-point scale. Reference article, Radiopaedia.org (Accessed on 20 Sep 2024) doi:10.53347\/rID-32555","DOI":"10.53347\/rID-32555"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13550-021-00846-y","article-title":"The prognostic significance of [18F]FDG PET\/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)","volume":"11","author":"Sachpekidis","year":"2021","journal-title":"EJNMMI Res"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0056","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1148\/radiol.2019181949","article-title":"Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)","volume":"291","author":"Messiou","year":"2019","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.lpm.2024.104263_bib0057","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00259-019-04605-z","article-title":"Chemokine receptor-4 targeted PET\/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET\/CT","volume":"47","author":"Pan","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.lpm.2024.104263_bib0058","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cpet.2022.03.001","article-title":"18F-FDG Versus Non-FDG PET Tracers in Multiple Myeloma","volume":"17","author":"Hemrom","year":"2022","journal-title":"PET Clin"},{"issue":"1","key":"10.1016\/j.lpm.2024.104263_bib0059","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00259-013-2520-x","article-title":"(11)C-acetate as a new biomarker for PET\/CT in patients with multiple myeloma: initial staging and postinduction response assessment","volume":"41","author":"Lin","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.lpm.2024.104263_bib0060","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3348\/kjr.2022.0377","article-title":"Photon-Counting Detector CT: Key Points Radiologists Should Know","volume":"23","author":"Esquivel","year":"2022","journal-title":"Korean J Radiol"},{"issue":"5","key":"10.1016\/j.lpm.2024.104263_bib0061","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000531461","article-title":"Photon Counting Detector Computed Tomography: A New Frontier of Myeloma Bone Disease Evaluation","volume":"146","author":"Cook","year":"2023","journal-title":"Acta Haematol"},{"issue":"3","key":"10.1016\/j.lpm.2024.104263_bib0062","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/cancers14030606","article-title":"Machine Learning and Deep Learning Applications in Multiple Myeloma Diagnosis, Prognosis, and Treatment Selection","volume":"14","author":"Allegra","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lpm.2024.104263_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2019.108739","article-title":"Differentiating diffuse from focal pattern on Computed Tomography in multiple myeloma: Added value of a Radiomics approach","volume":"121","author":"Tagliafico","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.lpm.2024.104263_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.874847","article-title":"Application of 18F-FDG PET-CT Images Based Radiomics in Identifying Vertebral Multiple Myeloma and Bone Metastases","volume":"9","author":"Jin","year":"2022","journal-title":"Front Med"},{"issue":"10","key":"10.1016\/j.lpm.2024.104263_bib0065","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/RLI.0000000000000986","article-title":"Prediction of Bone Marrow Biopsy Results From MRI in Multiple Myeloma Patients Using Deep Learning and Radiomics","volume":"58","author":"Wennmann","year":"2023","journal-title":"Invest Radiol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498224000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498224000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T18:46:25Z","timestamp":1741027585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498224000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0755498224000423"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2024.104263","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2024.104263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104263"}}